Vista Finance LLC Sells 92 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Vista Finance LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,927 shares of the healthcare conglomerate’s stock after selling 92 shares during the quarter. UnitedHealth Group makes up approximately 2.0% of Vista Finance LLC’s portfolio, making the stock its 12th biggest holding. Vista Finance LLC’s holdings in UnitedHealth Group were worth $1,986,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Puff Wealth Management LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $273,000. Lord & Richards Wealth Management LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $515,000. Hickory Asset Management Inc. bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $559,000. CapWealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 9.2% in the 4th quarter. CapWealth Advisors LLC now owns 833 shares of the healthcare conglomerate’s stock worth $421,000 after buying an additional 70 shares during the last quarter. Finally, WealthPlan Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 32.8% during the 4th quarter. WealthPlan Investment Management LLC now owns 1,250 shares of the healthcare conglomerate’s stock worth $632,000 after acquiring an additional 309 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Price Performance

UNH stock opened at $523.48 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a 50-day moving average of $523.11 and a 200 day moving average of $563.18. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.